Vitamin D and prostate cancer prognosis: a Mendelian randomization study.

doi:10.1007/s00345-015-1646-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.

World journal of urology - 1 Apr 2016

Trummer Olivia, Langsenlehner Uwe, Krenn-Pilko Sabine, Pieber Thomas R, Obermayer-Pietsch Barbara, Gerger Armin, Renner Wilfried, Langsenlehner Tanja

Abstract excerpt

PURPOSE: Decreased vitamin D levels have been associated with prostate cancer, but it is unclear whether this association is causal. A functional single-nucleotide polymorphism (SNP) in the group-specific component (GC) gene (T > G, rs2282679) has been associated with 25-hydroxy (25-OH) vitamin D and 1.25 dihydroxy (1.25-OH2) vitamin D levels. METHODS: To examine the hypothesized inverse relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Austria

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Disease Progression

Share to DNA, Neoplasm

Share to Mendelian Randomization Analysis

Share to Prostatic Neoplasms

Share to Survival Rate

Share to Vitamin D-Binding Protein

Source

Open in PubMed

Identifiers

PMID: 26209090
DOI: 10.1007/s00345-015-1646-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.PMID 26209090Read ↗

Vitamin D pathway gene variants and prostate cancer prognosis.Semantic proximity Read ↗

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.Semantic proximity Read ↗

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.Semantic proximity Read ↗

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.Semantic proximity Read ↗

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Semantic proximity Read ↗

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.Semantic proximity Read ↗

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.Semantic proximity Read ↗

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.